Kidney transplantation, bioengineering and regeneration: An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair

Jeffrey Rogers, Ravi Katari, Sheyna Gifford, Riccardo Tamburrini, Lauren Edgar, Marcia R. Voigt, Sean V. Murphy, Daniel Igel, Sara Mancone, Tyler Callese, Nicola Colucci, Majid Mirzazadeh, Andrea Peloso, Joao Paulo Zambon, Alan C. Farney, Robert J. Stratta, Giuseppe Orlando

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Kidney transplantation (KT), as a modality of renal replacement therapy (RRT), has been shown to be both economically and functionally superior to dialysis for the treatment of end-stage renal disease (ESRD). Progress in KT is limited by two major barriers: a) a chronic and burgeoning shortage of transplantable organs and b) the need for chronic immunosuppression following transplantation. Although ground-breaking advances in transplant immunology have improved patient survival and graft durability, a new pathway of innovation is needed in order to overcome current obstacles. Regenerative medicine (RM) holds the potential to shift the paradigm in RRT, through organ bioengineering. Manufactured organs represent a potentially inexhaustible source of transplantable grafts that would bypass the need for immunosuppressive drugs by using autologous cells to repopulate extracellular matrix (ECM) scaffolds. This overview discusses the current status of renal transplantation while reviewing the most promising innovations in RM therapy as applied to RRT.

Original languageEnglish
Pages (from-to)169-182
Number of pages14
JournalExpert Review of Clinical Immunology
Volume12
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Bioengineering
Renal Replacement Therapy
Allergy and Immunology
Kidney Transplantation
Regeneration
Regenerative Medicine
Transplants
Graft Survival
Immunosuppressive Agents
Immunosuppression
Chronic Kidney Failure
Extracellular Matrix
Dialysis
Transplantation
Therapeutics
Pharmaceutical Preparations

Keywords

  • Bioengineering
  • Decellularization
  • Extracellular matrix
  • Kidney transplantation
  • Regenerative medicine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Kidney transplantation, bioengineering and regeneration : An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. / Rogers, Jeffrey; Katari, Ravi; Gifford, Sheyna; Tamburrini, Riccardo; Edgar, Lauren; Voigt, Marcia R.; Murphy, Sean V.; Igel, Daniel; Mancone, Sara; Callese, Tyler; Colucci, Nicola; Mirzazadeh, Majid; Peloso, Andrea; Zambon, Joao Paulo; Farney, Alan C.; Stratta, Robert J.; Orlando, Giuseppe.

In: Expert Review of Clinical Immunology, Vol. 12, No. 2, 01.02.2016, p. 169-182.

Research output: Contribution to journalArticle

Rogers, J, Katari, R, Gifford, S, Tamburrini, R, Edgar, L, Voigt, MR, Murphy, SV, Igel, D, Mancone, S, Callese, T, Colucci, N, Mirzazadeh, M, Peloso, A, Zambon, JP, Farney, AC, Stratta, RJ & Orlando, G 2016, 'Kidney transplantation, bioengineering and regeneration: An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair', Expert Review of Clinical Immunology, vol. 12, no. 2, pp. 169-182. https://doi.org/10.1586/1744666X.2016.1112268
Rogers, Jeffrey ; Katari, Ravi ; Gifford, Sheyna ; Tamburrini, Riccardo ; Edgar, Lauren ; Voigt, Marcia R. ; Murphy, Sean V. ; Igel, Daniel ; Mancone, Sara ; Callese, Tyler ; Colucci, Nicola ; Mirzazadeh, Majid ; Peloso, Andrea ; Zambon, Joao Paulo ; Farney, Alan C. ; Stratta, Robert J. ; Orlando, Giuseppe. / Kidney transplantation, bioengineering and regeneration : An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. In: Expert Review of Clinical Immunology. 2016 ; Vol. 12, No. 2. pp. 169-182.
@article{3c389c4a18c5414dbbde8c43a04e7d26,
title = "Kidney transplantation, bioengineering and regeneration: An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair",
abstract = "Kidney transplantation (KT), as a modality of renal replacement therapy (RRT), has been shown to be both economically and functionally superior to dialysis for the treatment of end-stage renal disease (ESRD). Progress in KT is limited by two major barriers: a) a chronic and burgeoning shortage of transplantable organs and b) the need for chronic immunosuppression following transplantation. Although ground-breaking advances in transplant immunology have improved patient survival and graft durability, a new pathway of innovation is needed in order to overcome current obstacles. Regenerative medicine (RM) holds the potential to shift the paradigm in RRT, through organ bioengineering. Manufactured organs represent a potentially inexhaustible source of transplantable grafts that would bypass the need for immunosuppressive drugs by using autologous cells to repopulate extracellular matrix (ECM) scaffolds. This overview discusses the current status of renal transplantation while reviewing the most promising innovations in RM therapy as applied to RRT.",
keywords = "Bioengineering, Decellularization, Extracellular matrix, Kidney transplantation, Regenerative medicine",
author = "Jeffrey Rogers and Ravi Katari and Sheyna Gifford and Riccardo Tamburrini and Lauren Edgar and Voigt, {Marcia R.} and Murphy, {Sean V.} and Daniel Igel and Sara Mancone and Tyler Callese and Nicola Colucci and Majid Mirzazadeh and Andrea Peloso and Zambon, {Joao Paulo} and Farney, {Alan C.} and Stratta, {Robert J.} and Giuseppe Orlando",
year = "2016",
month = "2",
day = "1",
doi = "10.1586/1744666X.2016.1112268",
language = "English",
volume = "12",
pages = "169--182",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Kidney transplantation, bioengineering and regeneration

T2 - An originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair

AU - Rogers, Jeffrey

AU - Katari, Ravi

AU - Gifford, Sheyna

AU - Tamburrini, Riccardo

AU - Edgar, Lauren

AU - Voigt, Marcia R.

AU - Murphy, Sean V.

AU - Igel, Daniel

AU - Mancone, Sara

AU - Callese, Tyler

AU - Colucci, Nicola

AU - Mirzazadeh, Majid

AU - Peloso, Andrea

AU - Zambon, Joao Paulo

AU - Farney, Alan C.

AU - Stratta, Robert J.

AU - Orlando, Giuseppe

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Kidney transplantation (KT), as a modality of renal replacement therapy (RRT), has been shown to be both economically and functionally superior to dialysis for the treatment of end-stage renal disease (ESRD). Progress in KT is limited by two major barriers: a) a chronic and burgeoning shortage of transplantable organs and b) the need for chronic immunosuppression following transplantation. Although ground-breaking advances in transplant immunology have improved patient survival and graft durability, a new pathway of innovation is needed in order to overcome current obstacles. Regenerative medicine (RM) holds the potential to shift the paradigm in RRT, through organ bioengineering. Manufactured organs represent a potentially inexhaustible source of transplantable grafts that would bypass the need for immunosuppressive drugs by using autologous cells to repopulate extracellular matrix (ECM) scaffolds. This overview discusses the current status of renal transplantation while reviewing the most promising innovations in RM therapy as applied to RRT.

AB - Kidney transplantation (KT), as a modality of renal replacement therapy (RRT), has been shown to be both economically and functionally superior to dialysis for the treatment of end-stage renal disease (ESRD). Progress in KT is limited by two major barriers: a) a chronic and burgeoning shortage of transplantable organs and b) the need for chronic immunosuppression following transplantation. Although ground-breaking advances in transplant immunology have improved patient survival and graft durability, a new pathway of innovation is needed in order to overcome current obstacles. Regenerative medicine (RM) holds the potential to shift the paradigm in RRT, through organ bioengineering. Manufactured organs represent a potentially inexhaustible source of transplantable grafts that would bypass the need for immunosuppressive drugs by using autologous cells to repopulate extracellular matrix (ECM) scaffolds. This overview discusses the current status of renal transplantation while reviewing the most promising innovations in RM therapy as applied to RRT.

KW - Bioengineering

KW - Decellularization

KW - Extracellular matrix

KW - Kidney transplantation

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=84957427028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957427028&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2016.1112268

DO - 10.1586/1744666X.2016.1112268

M3 - Article

AN - SCOPUS:84957427028

VL - 12

SP - 169

EP - 182

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 2

ER -